Zen Tech Q1 weak: consolidated PAT ₹31.9 Cr, down 40% YoY on margin squeeze
PAT -40% YoY · revenue -10.48% · margins compressing · beat vs street
₹141.64 Cr
-10.48% YoY
₹31.85 Cr
-40% YoY
19.81%
-9.7pp YoY
₹3.83
Zen Technologies opened FY27 with a soft quarter. Consolidated revenue of ₹141.64 Cr fell 10.5% YoY and 20.5% sequentially, while consolidated net profit of ₹31.85 Cr dropped 40% YoY. A ₹3.37 Cr exceptional fire-loss at subsidiary Unistring Tech (inventory damaged on 25 April, insurance survey still pending) accounts for part of the fall; adding it back lifts PAT to roughly ₹35.2 Cr, still ~34% below the year-ago ₹53.07 Cr. The miss is therefore operational, not a one-off.
Q1 FY-2027 vs prior quarters
The squeeze sits on the cost-of-materials line: consumption ran at ~59% of revenue versus ~18% a year ago, dragging EBITDA/operating margin to 27.3% from 40.9% YoY and net margin to 19.8% from 29.5%. This is a product-mix effect — heavier weighting of lower-margin hardware/product deliveries against last year's richer simulator mix — and it confirms the "temporary margin dip" management flagged on the Q4 concall. A quirk this quarter: minority interest swung to a ₹2.61 Cr loss, so profit attributable to shareholders (₹34.46 Cr, EPS ₹3.83) exceeded total net profit; the standalone entity fared better, with revenue down only 7.3% and PAT down 21.3%, as it carries neither the subsidiary fire-loss nor the minority drag.
The stock went into the print at ₹1,768, down 4.1% over the past month of trading.
Management reaffirms its cumulative revenue guidance of Rs. 4,000 crores for FY2027 and FY2028 combined, supported by a strong order book of which Rs. 1,000 crores is slated for execution in FY27. Despite a temporary margin dip, long-term targets of 35% operational EBITDA and 25% PAT remain intact. The company anticipa
— This quarter: missed
Against the Street's mechanically bearish model (Univest penciled ~₹98 Cr revenue / ~₹36 Cr PAT on an assumed ~38% revenue decline), the topline was a clear beat — the drop was far shallower than feared — though PAT landed a touch light. Versus management's own targets, however, the 19.8% net margin sits below the 25% PAT and 35% EBITDA bars reaffirmed on the last call, and Q1 revenue annualises well short of the cumulative ₹4,000 Cr FY27-28 guidance — a gap leaning on the ₹1,239 Cr consolidated order book and back-ended H2 execution (₹1,000 Cr slated for FY27). Order momentum continues (₹177.5 Cr MoD win on 21 July; drone-propulsion capacity expanding to 300,000 units). Alongside results the board reappointed whole-time director Shilpa Choudari, added an independent director, and — tellingly — extended the deadline to deploy unutilised QIP proceeds earmarked for acquisitions/inorganic growth by two years to August 2028, signalling capital deployment is running slower than planned.
W1
Margin recovery toward the reaffirmed 25% PAT / 35% EBITDA long-term targets — Q1 NPM of 19.8% sits well below.
W2
Order-book conversion: the ₹1,239 Cr book plus ₹1,000 Cr slated for FY27 execution must drive an H2 ramp to keep the cumulative ₹4,000 Cr FY27-28 guidance in reach, with Q1 at just ₹141.6 Cr.
W3
Deployment of extended QIP proceeds for inorganic growth by Aug 2028, and execution of management-flagged new products (AI interceptor drones, smart ammunition, anti-drone/export orders).
Soft Q1 backed by ₹2.5K Cr pipeline, but tenders delay execution
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit prior guidance on margin methodology (adjusted for one-offs, 35% underlying) but missed on order inflow velocity. Post-quarter ₹177.5 Cr is integration, not new procurement.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Soft Q1 (revenue -10.5%, PAT -33.5%) driven by fixed-cost leverage on planned low revenue; gross margins stable at 72.9%. ₹1.2K Cr order book provides cushion, but execution depends on government tendering which has not started—management explicitly stated 'no tenders have come out.' Guidance intact structurally but near-term visibility poor; risk: multi-quarter tendering delays. Hold reflects strong long-term case offset by near-term execution uncertainty.
₹141.6 Cr
Revenue · −10.5% YoY₹31.8 Cr
Reported PAT · −33.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Gross margin stable; EBITDA compression from fixed-cost leverage on low revenue
METGross 72.9% confirmed stable; EBITDA 27.3% vs 40.9% YoY; CFO cites Q1'26 had ₹7.65 Cr provision reversals
Revenue weighted Q2-Q3 per plan; on track with delivery schedules
OVERSTATEDQ1 delivered ₹141.6 Cr vs ₹178.1 Cr Q4, ₹158.2 Cr Q1'26; new orders only ₹44.6 Cr this quarter
₹2,500 Cr order book target by end-FY27 after execution
MixedCurrent ₹1,239 Cr + post-quarter ₹177.5 Cr = ₹1,416 Cr; needs ₹1,084 Cr new inflow in 3Q remaining
Strong order pipeline; ₹700-800 Cr simulator orders incoming
OVERSTATEDCFO: 'No simulator tenders have come out yet.' Post-quarter ₹177.5 Cr is integration order, not new procurement
Anti-drone: ₹800 Cr post-Sindoor; significant new order inflows in FY27
MISSNo anti-drone tenders floated. Ashok admits 'government has not floated any tenders in recent times.'
Earnings quality
What changed since the last call
EBITDA margin guidance softened
DowngradePrior: 35%; now: 'mid-30s' per CFO. Q1 at 27.3% reflects operating leverage, not structural change, but FY target reduced from guidance.
Order inflow timing delayed
DowngradeCFO acknowledged 'no tenders have come out' for simulators or anti-drone. Pipeline of Rs.700-800 Cr simulator orders unproven; no near-term execution confirmed.
Air Force simulator product entered
NewC295 flight simulator developed; Air Force now pursuing entry. Positive new channel but earlier stage than Army/Navy, long sales cycle.
Vector Technics propulsion venture scaling
NeutralCapacity expanded to 300K units; 50% queries from overseas. Revenue currently small; upside if drone segment orders accelerate (currently 'slowed down').
The Q&A
Analyst pressure was direct on two fronts: (1) Why margins compressed YoY despite revenue 'similar'—pressed Gautam Rathi hard; CFO held by citing Q1'26 provision releases (5% margin boost). (2) Order flow vs capability expansion mismatch—Gautam asked why 5-capability company shows weak order traction. CFO admitted it's demand, not supply; Ashok acknowledged 'difficult times' but blamed government tendering delays. Overall Q&A pressure was substantive but management held defensive posture credibly.
Margin compression YoY — Bala Murali Krishna, Oman Investment
AnsweredQ1'26 benefited from ₹7.65 Cr provision reversals (~5% margin boost); adjusted real margin was ~35%. This quarter has warranty + R&D charges; sequential margin 27.3% vs 28.6% Q4 is stable underlying run-rate.
Order book trajectory — Bala Murali Krishna, Oman Investment
Answered₹2,500 Cr after execution. Pipeline 'very healthy'; will convert once government procurement starts.
₹4K Cr cumulative guidance risk — Bala Murali Krishna, Oman Investment
PartialYes, ₹800 Cr anti-drone 'post-Sindoor' orders expected; simulator pipeline robust; also tapping North America/EU (TAM ~$10 Bn). But first tenders must come from government.
Simulator market slowdown — Pawan Punjabi, Viansh Ventures
Partial₹177 Cr order just received (integration); ₹700-800 Cr more in pipeline; government increasing simulator budget; Air Force entry (C295) a crucial step. Gap in orders but starting to come now.
HyperStrike interceptor drone status — Pawan Punjabi, Viansh Ventures
PartialDemonstrated payloads/integration; flying at 300 km/h+ comfortably; still testing physics limits with full payload. On track structurally but timing pushing beyond FY28.
US market opportunity quantification — Akshay Kaila, AK Investment
AnsweredVery difficult market; pursuing FOCI, ITAR clearances now; aligning with prime vendors; modest ambition: $100 Mn by year 3. Long-term game; no big news expected 1-2 years.
Capability-vs-order mismatch — Gautam Rathi, CWC
AnsweredSimulators & anti-drone mature; sizable inflow past months. Robotics taking time (2-3 yrs). Autonomous vehicles future investment. Demand-limited, not supply-limited; no tenders out yet. Once tenders come, orders 'very, very fast.'
Anti-drone tender delays — Gautam Rathi, CWC
AnsweredDemand-limited. No tenders have come out. Government has not floated tenders recently. Issue is government, not Zen. When they float, we'll bid and win fast (few months to finalize).
Tank simulator order recurrence — Sanjeev Zarbade, Antec Limited
AnsweredThis ₹177 Cr is integration only, not new procurement. TAM is 2,400+ simulators (4,000 tanks × 6 operators × 200 training hours). This order is 'very, very small part.' 10-year lifecycle; AMC from year 3 onwards drives recurring revenue.
Order velocity change (12-month vs multi-year) — Dipen Vakil, Phillip Capital
AnsweredGovernment in fast-track mode (12-month cycle) for urgent procurement; regular procurement still multi-year. Getting more FTP orders but large deals still via regular channels.
Expected order wins FY27 — Dipen Vakil, Phillip Capital
PartialWon't predict precisely; but ₹700-800 Cr simulators incoming; anti-drone will be 'thousands of Crores' later. 'Very large market'; multiple players will benefit.
Guidance
FY27 revenue weighted Q2-Q3 execution; ₹1,000 Cr execution in FY27 (unchanged from prior guidance)
MediumQ1 came in ₹141.6 Cr as planned low-revenue quarter. Order book ₹1.2K Cr supports execution but tendering delays a risk.
Order book to reach ₹2,500 Cr by FY27 end after execution
LowNeeds ₹1.1K Cr new inflow in 3 quarters; ₹177.5 Cr post-quarter is integration order, not new production. Simulator & anti-drone tenders have not been floated.
₹4,000 Cr cumulative FY27-28 revenue unchanged; ~₹2,000 Cr from simulators
MediumMulti-year guidance intact but near-term (FY27) execution now flagged as demand-dependent; no tenders floated so far.
Full-year FY27 EBITDA margin 'mid-30s' (guidance softened from 35%)
MediumQ1 at 27.3% explained by fixed-cost leverage on low Q1 revenue. As revenue scales Q2-Q3, margin recovery expected.
PAT margin 25% long-term target maintained
MediumQ1 at ~24.3% (reported); adjusted ~26% ex-exceptional loss. Consistent with long-term 25% if revenue grows as guided.
R&D investment in robotics, autonomous vehicles, laser weapons ongoing
HighIncremental R&D ₹4.25 Cr this quarter. 2-3 year horizon for maturity. Management signaled 'heavy investment' in future capabilities.
Risks the call surfaced
Government tendering delay
HighCFO explicitly stated 'no tenders have come out' for simulators or anti-drone. ₹2.5K Cr FY27 order book target and ₹4K Cr cumulative guidance both depend on multi-quarter tendering. Extended delay could slip orders to FY28.
Order inflow volatility
HighQ1 new orders only ₹44.6 Cr vs ₹141.6 Cr execution creates high dependency on backlog conversion. ₹177.5 Cr post-quarter is integration (non-revenue increasing). If large orders (₹700-800 Cr simulator) don't materialize in expected quarters, revenue could miss.
Margin recovery execution
MediumCFO's entire margin recovery thesis (27.3% → 'mid-30s') rests on revenue scaling Q2-Q3 to absorb fixed costs. If orders delay and Q2-Q3 revenue doesn't materialize, fixed-cost burden remains and margins compress further.
New product adoption risk
MediumRobotics (Vrishabh), autonomous vehicles, laser weapons, interceptor drones all 2-3 year timeline to commercialization. Early-stage R&D carries execution/technology obsolescence risk. Heavy capex with no near-term revenue.
Working capital stress if orders slip
MediumWC cycle 257 days (elevated from year-end) due to supplier advances + inventory buildup for order execution. If orders delay, this inventory becomes stranded and cash tied up.
Management
Score 6/10. Transparent on constraints (no tenders floated); acknowledged 'difficult times' for company. Defensive posture in Q&A but direct answers to hard questions on margin compression and order delays. Candid on timing uncertainty ('would love to predict but can't'). Track record mixed. Prior guidance on ₹1K Cr FY27 execution reaffirmed but Q1 shows weak order inflow (₹44.6 Cr). ₹177.5 Cr post-quarter order is integration, not new revenue-adding production. Margin guidance softened from 35% to 'mid-30s.' Credibility weakened on near-term.
1 · Q2 FY27
Government tenders for simulators and anti-drone systems floated; Rs.700-800 Cr simulator pipeline to materialize
2 · H2 FY27
Order book to cross ₹2,500 Cr; revenue scale-up via Q2-Q3 execution
3 · FY2028
New products (robotics, autonomous vehicles) mature; AMC on simulator base accelerates
Hold reflects strong long-term case offset by near-term execution uncertainty.
Pipeline Robust, Execution Stalled—The Real Margin Story
Profit fell 33.5% YoY, but strip the fire loss and fixed-cost leverage, the core business is stable. The real issue: no government tenders have come out yet, and guidance recovery depends on that tap turning on.
₹31.8 Cr
-33.5% YoY
₹3.4 Cr
subsidiary, insured
~₹35.2 Cr
-24% YoY (organic)
72.9%
stable YoY & QoQ
The headline profit is down a third, but the real story sits underneath. A ₹3.4 crore fire loss at a subsidiary masks the underlying number, which adjusts to roughly ₹35.2 crore—still down nearly a quarter YoY, but not a collapse. Strip that, and you're left with the margin story: gross margins are rock-solid at 72.9%, flat year-on-year. The EBITDA compression from 40.9% to 27.3% is entirely fixed-cost leverage. This was a planned low-revenue quarter. The company executed ₹141.6 crore against an order book weighted for Q2-Q3 delivery. That's the design, not the disease.
Where the margin pressure comes from (and where it's supposed to go)
Management's margin story is straightforward: Q1 was architected as a trough. The order book (₹1,239 crore current, ₹1,416 crore post-quarter including a ₹177.5 crore integration order) is weighted for H2 execution. As revenue scales in Q2 and Q3, fixed costs—which the CFO confirms are 'a significant portion' of the cost base—spread across a larger revenue denominator, margin recovery to 'mid-30s' by year-end. On the numbers, this math works: if revenue scales as guided, EBITDA margin at 27.3% today should recover to 30–35% once Q2-Q3 hit their targets.
The catch is the 'if.' Q1 saw only ₹44.6 crore in new order inflows—31% of the ₹141.6 crore executed. That's not execution on backlog; that's order book depletion. And here's where the call took a hard turn: the CFO was blunt about why. 'No tenders have come out,' he said, not once but repeatedly. Simulators, anti-drone systems, the company's two largest near-term revenue pools—both gated by government procurement cycles. The ₹700–800 crore simulator pipeline and ₹800 crore anti-drone opportunity cited by management exist as expectations, not signed contracts.
The issue is not with Zen, but the government has not floated any tenders in the recent times. As and when they float, we will be bidding and we will hear good news.
That is both honesty and a red flag. Zen is not executing a strategy it controls; it's waiting for a tap (government procurement) to turn on. The company has reaffirmed its ₹4,000 crore cumulative guidance for FY27-FY28 and its ₹1,000 crore FY27 execution, but the near-term visibility has taken a step backward.
Management's claims—what holds up, what doesn't
Q1 low-revenue quarter by design; Q2-Q3 weighted for execution
SupportedOrder book ₹1.2K Cr covers 8–9 months at historical run-rate. Q4 ₹178.1 Cr vs. Q1 ₹141.6 Cr and prior-year ₹158.2 Cr support a trough narrative.
Gross margin stable; EBITDA compression from fixed-cost leverage, not product mix
SupportedGross 72.9% confirmed stable YoY and QoQ. EBITDA delta (−13.6pp) reconciles to fixed costs on lower revenue base.
₹700–800 Cr simulator pipeline incoming; ₹800 Cr anti-drone post-Sindoor
OverstatedNo tenders floated. CFO: 'No tenders have come out.' Post-quarter ₹177.5 Cr order is integration, not new procurement. Pipeline exists as expectation.
₹2,500 Cr order book target by FY27 end after execution
MixedNeeds ₹1.1K Cr new inflow in 3 remaining quarters. Zero tenders floated so far. Order inflow this quarter ₹44.6 Cr. Target is structural but timing contingent on government action.
Anti-drone orders expected significant in FY27
ContradictedNo anti-drone tenders have been issued. Ashok acknowledged 'government has not floated any tenders.' ₹800 Cr is a post-Sindoor aspiration, not a pipeline.
What changed on this call versus prior guidance
EBITDA margin guidance softened to 'mid-30s' (from 35% prior)
Order inflow velocity explicitly demand-gated; no tenders floated acknowledged
Air Force entry (C295 flight simulator) now in shortlist for future tenders
Vector Technics (propulsion subsidiary) capacity expanded to 300K units; overseas interest noted
Management tone shifted from prior calls' optimism to guarded caution on near-term visibility
Earnings quality and risks
Government tendering delay (explicit risk flagged on call)
HighCFO said 'no tenders have come out.' The ₹2.5K Cr EOY order book target and ₹4K Cr cumulative guidance both depend on ₹700–800 Cr simulator + ₹800 Cr anti-drone tenders materializing in the next 3 quarters. If this slips to FY28, revenue and margin targets miss and order book depletes further.
Order inflow velocity (₹44.6 Cr new vs. ₹141.6 Cr execution)
HighNet inflow-to-execution ratio of 31% is unsustainable. The order book is shrinking quarter-on-quarter without new signings. A multi-quarter tendering drought forces the company to live off backlog, which then depletes. If inflow remains weak, execution visibility for H2 becomes questionable.
Margin recovery dependent on Q2-Q3 revenue scaling
MediumCFO's entire 'mid-30s' EBITDA recovery thesis rests on Q2 and Q3 revenue spikes to 200%+ of Q1 levels. If tendering delays push orders out, Q2-Q3 revenue doesn't hit, and fixed costs remain spread thin. Margins stay compressed.
New product commercialization risk (robotics, interceptor drones, autonomous vehicles)
MediumAll 2–3 year horizon, heavy R&D. Incremental ₹4.25 crore R&D spend this quarter. Timing and commercialization uncertainty. If core orders slip, R&D burn becomes more visible as a drag on near-term PAT.
Working capital cycle elevation (257 days, up from year-end)
MediumElevated due to supplier advances and inventory buildup for order execution. If orders slip and inventory becomes stranded, cash tie-up lengthens. Strong balance sheet (₹1.2K crore) provides buffer, but a multi-quarter delay exposes this as a stress point.
How the street is reading it—price action and positioning
₹1,624.2
off ATH ₹2,016.1 (−19.4%)
₹1,624.2
below ₹1,771.54
25
oversold
₹1,223–₹2,016
+32.8% off low
The market's verdict on the print was swift: day-1 selloff of −4.51% held and extended to −8.13% by day 5. The initial pop never materialized; selling was orderly, not panic. That suggests the market repriced the order inflow risk and tendering visibility gap as justified concerns, not a temporary overreaction. The stock is now 19.4% off its all-time high, down from mid-year geopolitical highs, and RSI is oversold (25), raising the question of whether the selloff has overshot or whether there's more pain if Q2 inflows also disappoint.
Ownership flows offer a clue: FII added 0.44pp and DII added 2.21pp in the latest quarter, suggesting institutional investors did not flee. Instead, the selling has been retail or momentum-based. That's a tell. It says institutions see near-term pain (tendering delays, order velocity) but long-term structural value (₹4K crore guidance, simulator TAM, geopolitical tailwind) still intact. The oversold RSI suggests a tactical bounce is possible, but the fundamental recovery (back to ₹1,800+) depends on tenders coming and Q2 inflows proving the order book is replenishing, not depleting.
What to watch next quarter
1 · Q2 order inflow and tender calendar
If ₹100+ crore in new orders land in Q2 (double this quarter's ₹44.6 Cr), the tendering tap has opened. If inflow stays anemic, order book depletion accelerates and FY27 targets are at risk. Management should provide a tender schedule or timeline for simulator and anti-drone RFQs.
2 · Margin recovery in Q2-Q3 (validation of fixed-cost thesis)
If Q2-Q3 revenue scales as guided and EBITDA margin improves toward 30–35%, the fixed-cost story holds and confidence returns. If margins stay compressed (25–27%) despite higher revenue, it signals either input cost inflation or lower-than-expected orders in the mix.
3 · Post-quarter order announcements
Management often logs orders post-quarter (this quarter: ₹177.5 Cr integration). Watch for any Q2 announcements of simulator or anti-drone tenders won. That will be the early signal for whether government action is accelerating.
ZEN Technologies is not in distress—its balance sheet is fortress-like, margins are stable at the gross level, and the multi-year TAM (simulators, anti-drone, export to North America and Europe) is real. But the near term is now explicitly contingent on a variable Zen doesn't control: government procurement calendars. The order book provides a 9-month runway, but Q1's weak inflow (₹44.6 crore) and the CFO's blunt acknowledgment that 'no tenders have come out' have reset expectations. The guidance is intact, but credibility is now conditional on tendering accelerating.
Rating: Hold. The stock has repriced 19% off highs and RSI is oversold (25), suggesting tactical opportunity for existing holders to add on dips. But new positions should wait for visibility on Q2 inflows and a confirmed tender schedule. The number to track is adjusted PAT and order inflow velocity—those two will tell you whether this is a structural pause (buy the dip) or a multi-quarter delay (hold for clarity). Once tenders come, this franchise will scale fast. Until then, patience wins.